Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kihei Terada is active.

Publication


Featured researches published by Kihei Terada.


Journal of Clinical Investigation | 1998

Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.

Kazunaga Agematsu; Haruo Nagumo; Koji Shinozaki; Sho Hokibara; Kozo Yasui; Kihei Terada; Naohisa Kawamura; Tsuvoshi Toba; Shigeaki Nonoyama; Hans D. Ochs; Atsushi Komiyama

The present study analyzed peripheral blood B cell populations separated by IgD and CD27 expression in six males with X-linked hyper-IgM syndrome (XHIM). Costimulation of mononuclear cells from most of the patients induced no to low levels of class switching from IgM to IgG and IgA with Staphylococcus aureus Cowan strain (SAC) plus IL-2 or anti-CD40 mAb (anti-CD40) plus IL-10. Measurable levels of IgE were secreted in some of the patients after stimulation with anti-CD40 plus IL-4. Costimulation with SAC plus IL-2 plus anti-CD40 plus IL-10 yielded secretion of significant levels of IgG in addition to IgM, but not IgA. The most striking finding was that peripheral blood B cells from all of the six patients were composed of only IgD+ CD27(-) and IgD+ CD27(+) B cells; IgD- CD27(+) memory B cells were greatly decreased. IgD+ CD27(+) B cells from an XHIM patient produced IgM predominantly. Our data indicate that the low response of IgG production in XHIM patients is due to reduced numbers of IgD- CD27(+) memory B cells. However, the IgG production can be induced by stimulation of immunoglobulin receptors and CD40 in cooperation with such cytokines as IL-2 and IL-10 in vitro.


Antimicrobial Agents and Chemotherapy | 2013

Nationwide Surveillance of Macrolide-Resistant Mycoplasma pneumoniae Infection in Pediatric Patients

Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Tokio Wakabayashi; Satoko Ogita; T. Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi

ABSTRACT We conducted nationwide surveillance to investigate regional differences in macrolide-resistant (MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae in pediatric patients gradually increased between 2008 and 2012. Although regional differences were observed, high levels of MR genes were detected in all seven surveillance areas throughout Japan and ranged in prevalence from 50% to 93%. These regional differences were closely related to the previous administration of macrolides.


Journal of Medical Virology | 1998

Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete.

Kihei Terada; Takahiro Niizuma; Shoji Kawano; Naoki Kataoka; Takeshi Akisada; Yozo Orita

On the basis of alterations in varicella‐zoster virus (VZV) antibody titers, it appears that Bells palsy in some patients could be associated with VZV reactivation, that is, zoster sine herpete. To obtain stronger evidence of this association, polymerase chain reaction (PCR) was used to detect VZV DNA in auricular lesions or peripheral blood mononuclear cells (PBMCs) from Bells palsy or Ramsay Hunt syndrome patients. VZV DNA was detected in the auricular lesions of Ramsay Hunt syndrome, in PBMCs from 2 Ramsay Hunt syndrome patients, and in 4 of 17 samples from 16 Bells palsy patients. Three of these four positive patients were thought to have zoster sine herpete because of hearing difficulty, vertigo, and pain. VZV IgM antibodies were positive in 1 of the 2 patients with Ramsay Hunt syndrome, and in 2 of the 17 samples from the Bells palsy patients. VZV IgG antibody titers during the acute phase were significantly higher in the patients positive for the PCR or VZV IgM antibody than in those negative for them. These findings provide evidence that Bells palsy in some patients could be associated with VZV reactivation. J. Med. Virol. 56:359–363, 1998.


Journal of General Virology | 1998

APOPTOSIS OF CD4+ T LYMPHOCYTES IN HUMAN HERPESVIRUS-6 INFECTION

Masaki Yasukawa; Yasuhiro Inoue; Hideki Ohminami; Kihei Terada; Shigeru Fujita

The present authors have recently reported that inoculation with human herpesvirus-6 (HHV-6) renders CD4+ T lymphocytes susceptible to apoptosis in vitro. In order to confirm that apoptosis of CD4+ T lymphocytes also occurs in HHV-6 infection in vivo, apoptosis of lymphocytes isolated from nine patients with exanthem subitum and from an adult patient with severe HHV-6 infection was examined. Peripheral blood mononuclear cells were cultured for 3 days and apoptosis of lymphocytes was then examined by flow cytometry of propidium iodide-stained DNA. The percentages of hypodiploid DNA, indicating apoptosis, in lymphocytes from 10 patients with HHV-6 infection were significantly higher than those from five infant patients with noninfectious diseases and five healthy adults (P < 0-0002). DNA fragmentation was also detected by agarose gel electrophoresis in lymphocytes from patients with HHV-6 infection. Apoptosis appeared to occur predominantly in CD4+ T lymphocytes and HHV-6 was isolated from the CD4+ T lymphocyte fraction. These data demonstrate that HHV-6 renders CD4+ T lymphocytes susceptible to apoptosis in vivo.


Antimicrobial Agents and Chemotherapy | 2013

Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients

Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Satoko Ogita; T. Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi

ABSTRACT The importance of macrolide-resistant (MR) Mycoplasma pneumoniae has become much more apparent in the past decade. We investigated differences in the therapeutic efficacies of macrolides, minocycline, and tosufloxacin against MR M. pneumoniae. A total of 188 children with M. pneumoniae pneumonia confirmed by culture and PCR were analyzed. Of these, 150 patients had a strain with an MR gene and 134 had one with an A-to-G mutation at position 2063 of M. pneumoniae 23S rRNA domain V. Azithromycin (n = 27), clarithromycin (n = 23), tosufloxacin (n = 62), or minocycline (n = 38) was used for definitive treatment of patients with MR M. pneumoniae. Defervescence within 48 h after the initiation of antibiotic therapy was observed in 41% of the patients in the azithromycin group, 48% of those in the clarithromycin group, 69% of those in the tosufloxacin group, and 87% of those in the minocycline group. The average number of days of fever after the administration of antibiotic treatment was lower in the minocycline and tosufloxacin groups than in the macrolide groups. The decrease in the M. pneumoniae burden, as estimated by the number of DNA copies, after 48 to 96 h of treatment was more rapid in patients receiving minocycline (P = 0.016) than in those receiving tosufloxacin (P = 0.049), azithromycin (P = 0.273), or clarithromycin (P = 0.107). We found that the clinical and bacteriological efficacies of macrolides against MR M. pneumoniae pneumonia was low. Our results indicated that minocycline rather than tosufloxacin can be considered the first-choice drug for the treatment of M. pneumoniae pneumonia in children aged ≥8 years.


Respirology | 2012

Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.

Yasuhiro Kawai; Naoyuki Miyashita; Tetsuya Yamaguchi; Aki Saitoh; Eisuke Kondoh; Hiroki Fujimoto; Hideto Teranishi; Mika Inoue; Tokio Wakabayashi; Hiroto Akaike; Satoko Ogita; Kozo Kawasaki; Kihei Terada; Fumio Kishi; Kazunobu Ouchi

Background and objective:  Since 2000, the prevalence of macrolide‐resistant (MR) Mycoplasma pneumoniae has increased among paediatric patients in Japan. To determine the efficacy of macrolides against MR M. pneumoniae pneumonia, microbiological and clinical efficacies were compared during the antibiotic treatment.


Epilepsia | 1997

Epilepsy in Peroxisomal Diseases

Yukitoshi Takahashi; Yasuyuki Suzuki; Kaori Kumazaki; Yuzo Tanabe; Shinjiro Akaboshi; Kiyokuni Miura; Nobuyuki Shimozawa; Naomi Kondo; Toshihiro Nishiguchi; Kihei Terada; Tadao Orii

Summary: Purpose: To clarify the electroclinical manifestation of epileptic seizures and the evolution of epilepsy in patients with peroxisomal diseases.


Scandinavian Journal of Infectious Diseases | 2004

Bilateral facial nerve palsy associated with Epstein-Barr virus infection with a review of the literature

Kihei Terada; Takahiro Niizuma; Yasuko Kosaka; Miwa Inoue; Satoko Ogita; Naoki Kataoka

A case of bilateral simultaneous facial nerve palsy associated with an Epstein-Barr virus (EBV) infection in a 14-month-old girl is described. Diagnosis of the EBV infection was based on the presence of 7% atypical lymphocytes, EBV-DNA and seroconversion in the VCA-IgG antibody, an EBV-specific antibody. Although bilateral facial nerve palsy is very rare, approximately 40% of the EBV-associated facial nerve palsy cases reported have been bilateral.


Pediatrics International | 2006

Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella–zoster virus association

Satoko Ogita; Kihei Terada; Takahiro Niizuma; Yasuko Kosaka; Naoki Kataoka

Background: The aim of this study was to clarify the clinical characteristics of facial nerve palsy and the frequency of varicella–zoster virus association in Japanese children, retrospectively.


Journal of Pediatric Hematology Oncology | 1998

Hemolytic anemia associated with cold agglutinin during chickenpox and a review of the literature

Kihei Terada; Tanaka H; Mori R; Kataoka N; Uchikawa M

PURPOSE To describe the findings and cause of anemia and jaundice in a 2-year-old boy. PATIENT AND METHODS This boy was admitted with a hemoglobin of 7.8 g/dL, a bilirubin of 1.8 mg/dL, and increased urobilinogen. RESULTS On the second day after admission, hemolytic anemia associated with an anti-I cold agglutinin was diagnosed, which was transient and recovered without any treatment. CONCLUSION This is a very rare complication of chickenpox; only five cases have been previously reported and these were all characterized by anti-Pr cold agglutinin with hemolytic anemia after the onset of chickenpox. We report the first case of hemolytic anemia associated with an anti-I cold agglutinin during the incubation period of chickenpox.

Collaboration


Dive into the Kihei Terada's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoko Ogita

Kawasaki Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shoji Kawano

Kawasaki Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsushi Kato

Kawasaki Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge